Go to navigation Go to content


HOME > About Us > History

History

2002

  • Access Bio established
  • Recognized as an ‘Emerging Bioscience Company’ by the New Jersey Economic Development Authority
  • Small Business Innovation Research (SBIR) Grant - Phase I: Scrub Typhus

2003

  • Small Business Technology Transfer (STTR) Grant - Phase I: Dengue Virus

2004

  • SBIR Grant - Phase II: Scrub Typhus
  • U.S. Department of Defense Project - Phase I: Leishmaniasis

2005

  • Supply of CareStart™ Malaria RDTs to MSF (Medecins Sans Frontieres, Doctors without Borders)

2006

  • CareStart™ Malaria RDT received MSF validation for its high quality

2009

  • CareStart™ Malaria RDT demonstrated the top performance in WHO RDT product evaluations (Round 1, 2, 3, 4)

2010

  • Production subsidiary established in Ethiopia

2011

  • Presentation of world’s first CareStart™ G6PD deficiency screening test at the American Society of Tropical Medicine and Hygiene

2013

  • Listed on the Korean Stock Exchange
  • Access Bio Korea established

2014

  • Establishment of R&D and production subsidiary in Seoul, Korea

All Menu